BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23377564)

  • 1. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.
    Shindoh J; Tzeng CW; Aloia TA; Curley SA; Zimmitti G; Wei SH; Huang SY; Mahvash A; Gupta S; Wallace MJ; Vauthey JN
    Ann Surg Oncol; 2013 Aug; 20(8):2493-500. PubMed ID: 23377564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.
    Yamashita S; Shindoh J; Mizuno T; Chun YS; Conrad C; Aloia TA; Vauthey JN
    J Hepatol; 2017 Jul; 67(1):56-64. PubMed ID: 28192187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy.
    Omichi K; Yamashita S; Cloyd JM; Shindoh J; Mizuno T; Chun YS; Conrad C; Aloia TA; Vauthey JN; Tzeng CD
    J Gastrointest Surg; 2018 Jan; 22(1):60-67. PubMed ID: 28585106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?
    Narita M; Oussoultzoglou E; Fuchshuber P; Pessaux P; Chenard MP; Rosso E; Nobili C; Jaeck D; Bachellier P
    Ann Surg Oncol; 2012 Aug; 19(8):2526-38. PubMed ID: 22395987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.
    Kishi Y; Zorzi D; Contreras CM; Maru DM; Kopetz S; Ribero D; Motta M; Ravarino N; Risio M; Curley SA; Abdalla EK; Capussotti L; Vauthey JN
    Ann Surg Oncol; 2010 Nov; 17(11):2870-6. PubMed ID: 20567921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study.
    Young AL; Wilson D; Ward J; Biglands J; Guthrie JA; Prasad KR; Toogood GJ; Robinson PJ; Lodge JP
    HPB (Oxford); 2012 Mar; 14(3):194-200. PubMed ID: 22321038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria.
    Kobayashi Y; Kiya Y; Nishioka Y; Hashimoto M; Shindoh J
    HPB (Oxford); 2020 Feb; 22(2):258-264. PubMed ID: 31326264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
    Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
    Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
    Kremer M; Manzini G; Hristov B; Polychronidis G; Mokry T; Sommer CM; Mehrabi A; Weitz J; Büchler MW; Schemmer P
    J Am Coll Surg; 2015 Sep; 221(3):717-728.e1. PubMed ID: 26232303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections.
    Martel G; Cieslak KP; Huang R; van Lienden KP; Wiggers JK; Belblidia A; Dagenais M; Lapointe R; van Gulik TM; Vandenbroucke-Menu F
    HPB (Oxford); 2015 Dec; 17(12):1051-7. PubMed ID: 26373675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associating Liver Partition and Portal vein ligation for Staged hepatectomy after pre-operative chemotherapy.
    Vondran FWR; Oldhafer F; Ringe KI; Wirth TC; Kleine M; Jäger MD; Klempnauer J; Bektas H
    ANZ J Surg; 2018 Apr; 88(4):E324-E328. PubMed ID: 28419692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Yamashita S; Sakamoto Y; Yamamoto S; Takemura N; Omichi K; Shinkawa H; Mori K; Kaneko J; Akamatsu N; Arita J; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2017 Jun; 24(6):1557-1568. PubMed ID: 28188502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.
    Shindoh J; Truty MJ; Aloia TA; Curley SA; Zimmitti G; Huang SY; Mahvash A; Gupta S; Wallace MJ; Vauthey JN
    J Am Coll Surg; 2013 Feb; 216(2):201-9. PubMed ID: 23219349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.
    Madoff DC; Abdalla EK; Gupta S; Wu TT; Morris JS; Denys A; Wallace MJ; Morello FA; Ahrar K; Murthy R; Lunagomez S; Hicks ME; Vauthey JN
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):215-25. PubMed ID: 15713922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.
    Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H
    Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity.
    Tanaka K; Matsuo K; Murakami T; Kawaguchi D; Hiroshima Y; Koda K; Endo I; Ichikawa Y; Taguri M; Tanabe M
    Eur J Surg Oncol; 2015 Apr; 41(4):506-12. PubMed ID: 25704556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy.
    Yoh T; Perrot A; Beaufrère A; Hobeika C; Sartoris R; Paradis V; Vilgrain V; Soubrane O; Cauchy F; Ronot M
    Eur Radiol; 2021 Aug; 31(8):5830-5839. PubMed ID: 33666699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution.
    Okabe H; Beppu T; Chikamoto A; Hayashi H; Yoshida M; Masuda T; Imai K; Mima K; Nakagawa S; Kuroki H; Nitta H; Ishiko T; Hashimoto D; Yamashita Y; Baba H
    Int J Clin Oncol; 2014 Aug; 19(4):614-21. PubMed ID: 23860603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two methods of future liver remnant volume measurement.
    Chun YS; Ribero D; Abdalla EK; Madoff DC; Mortenson MM; Wei SH; Vauthey JN
    J Gastrointest Surg; 2008 Jan; 12(1):123-8. PubMed ID: 17924174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases.
    Tanaka K; Shimada H; Matsuo K; Ueda M; Endo I; Togo S
    Eur J Surg Oncol; 2007 Apr; 33(3):329-35. PubMed ID: 17140759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.